Drug points: prolonged cholestasis associated with irbesartan.
Hariraj
R
R
Princess Alexandra Hospital, Harlow, Essex CM20 1QX.
Stoner
E
E
Jader
S
S
Preston
D M
DM
D000959:Antihypertensive Agents / Q000009:adverse effects*; D001713:Biphenyl Compounds / Q000009:adverse effects*; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D006801:Humans; D000077405:Irbesartan; D008099:Liver / Q000473:pathology / Q000503:physiopathology; D008111:Liver Function Tests; D008875:Middle Aged; D013777:Tetrazoles / Q000009:adverse effects*
D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan